New Self-assembled Supramolecular Bowls as Potent Anticancer Agents for Human Hepatocellular Carcinoma

Area of Science:

• Supramolecular chemistry
• Medicinal chemistry
• Cancer biology

Background:

• Hepatocellular carcinoma (HCC) remains a significant global health challenge.
• Development of novel therapeutic agents targeting cancer-specific pathways is crucial.
• Metal-based complexes offer unique mechanisms for cancer treatment.

Purpose of the Study:

• To design, synthesize, and evaluate the anticancer potential of Ruthenium (Ru)-based self-assembled supramolecular bowls.
• To elucidate the mechanism of action of these novel compounds in human hepatocellular cancer cells.
• To explore their ability to induce cancer cell apoptosis.

Main Methods:

• Synthesis and characterization of Ru-based supramolecular bowls.
• In vitro biological activity assays against human hepatocellular cancer cell lines.
• Investigation of reactive oxygen species (ROS) generation pathways.
• Analysis of apoptosis induction and signaling pathways.

Main Results:

• The Ru-based supramolecular bowls demonstrated potent anticancer activity.
• The compounds induced significant reactive oxygen species (ROS) production via enhanced fatty acid β-oxidation and altered glucose metabolism.
• Activation of the tricarboxylic acid cycle and electron transport system led to ROS hypergeneration, inducing apoptosis.
• Naphthalene-derived molecular bowls activated apoptosis through crosstalk between extrinsic and intrinsic pathways.

Conclusions:

• Ru-based self-assembled supramolecular bowls represent a promising new class of anticancer agents for hepatocellular cancer.
• The mechanism involves ROS overproduction and activation of classical apoptosis pathways.
• Further investigation into these supramolecular structures could lead to novel cancer therapeutics.